These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37238357)

  • 1. COVID-19 and Related Vaccinations in Children: Pathogenic Aspects of Oral Lesions.
    Di Spirito F; D'Ambrosio F; Di Palo MP; Giordano F; Coppola N; Contaldo M
    Children (Basel); 2023 Apr; 10(5):. PubMed ID: 37238357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Lesions Following Anti-SARS-CoV-2 Vaccination: A Systematic Review.
    Di Spirito F; Amato A; Di Palo MP; Contaldo M; D'Ambrosio F; Lo Giudice R; Amato M
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and Its Repercussions on Oral Health: A Review.
    Rusu LC; Ardelean LC; Tigmeanu CV; Matichescu A; Sauciur I; Bratu EA
    Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, Features and Degree of Association of Oral Lesions in COVID-19: A Systematic Review of Systematic Reviews.
    Di Spirito F; Iandolo A; Amato A; Caggiano M; Raimondo A; Lembo S; Martina S
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation.
    Yousaf AR; Cortese MM; Taylor AW; Broder KR; Oster ME; Wong JM; Guh AY; McCormick DW; Kamidani S; Schlaudecker EP; Edwards KM; Creech CB; Staat MA; Belay ED; Marquez P; Su JR; Salzman MB; Thompson D; Campbell AP;
    Lancet Child Adolesc Health; 2022 May; 6(5):303-312. PubMed ID: 35216660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of SARS-CoV-2-Specific Antibodies in Human Breast Milk and Their Neutralizing Capacity after COVID-19 Vaccination: A Systematic Review.
    Nicolaidou V; Georgiou R; Christofidou M; Felekkis K; Pieri M; Papaneophytou C
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of non-characteristic oral manifestations in COVID-19 - a scoping brief commentary.
    Hüpsch-Marzec H; Dziedzic A; Skaba D; Tanasiewicz M
    Med Pr; 2021 Dec; 72(6):685-692. PubMed ID: 34596170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial.
    Mallory RM; Formica N; Pfeiffer S; Wilkinson B; Marcheschi A; Albert G; McFall H; Robinson M; Plested JS; Zhu M; Cloney-Clark S; Zhou B; Chau G; Robertson A; Maciejewski S; Hammond HL; Baracco L; Logue J; Frieman MB; Smith G; Patel N; Glenn GM;
    Lancet Infect Dis; 2022 Nov; 22(11):1565-1576. PubMed ID: 35963274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges.
    Cooper DM; Afghani B; Byington CL; Cunningham CK; Golub S; Lu KD; Radom-Aizik S; Ross LF; Singh J; Smoyer WE; Lucas CT; Tunney J; Zaldivar F; Ulloa ER
    Pediatr Res; 2021 Nov; 90(5):966-970. PubMed ID: 33627824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transverse Myelitis Following SARS-CoV-2 Vaccination: A Pharmacoepidemiological Study in the World Health Organization's Database.
    Nguyen S; Bastien E; Chretien B; Sassier M; Defer G; Nehme A; Lelong-Boulouard V; Alexandre J; Fedrizzi S; Morice PM
    Ann Neurol; 2022 Dec; 92(6):1080-1089. PubMed ID: 36054163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granuloma annulare after SARS-CoV-2 vaccination: A case report and a literature review.
    Russo D; Accarino R; Varricchio S; Franca RA; Potestio L; Patruno C; Napolitano M; Mascolo M
    Pathol Res Pract; 2023 Feb; 242():154300. PubMed ID: 36638589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
    Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L
    Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Viral Infections With Oral Cavity Lesions: Role of SARS-CoV-2 Infection.
    La Rosa GRM; Libra M; De Pasquale R; Ferlito S; Pedullà E
    Front Med (Lausanne); 2020; 7():571214. PubMed ID: 33521007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrative review of oral manifestations in patients with COVID-19: signs directly related to SARS-CoV-2 infection or secondary findings?
    Reis VP; Bezerra AR; Maia ABP; Marques LC; Conde DC
    Int J Dermatol; 2022 Mar; 61(3):278-290. PubMed ID: 34541674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral lesions after COVID-19 vaccination: Immune mechanisms and clinical approach.
    Khazeei Tabari MA; Najary S; Khadivi G; Yousefi MJ; Samieefar N; Abdollahimajd F
    Infect Med (Beijing); 2022 Sep; 1(3):171-179. PubMed ID: 38014364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social and clinical impact of COVID-19 on patients with fibrodysplasia ossificans progressiva.
    Kou S; Kile S; Kambampati SS; Brady EC; Wallace H; De Sousa CM; Cheung K; Dickey L; Wentworth KL; Hsiao EC
    Orphanet J Rare Dis; 2022 Mar; 17(1):107. PubMed ID: 35246171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study.
    Luchetti Gentiloni MM; Paci V; Marconi V; Gigli M; Benfaremo D; Sordillo R; Macchini C; Massaccesi L; Perna GP; Offidani AM; Moroncini G
    Front Immunol; 2022; 13():859550. PubMed ID: 35386714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Safety of the BNT162b2 Messenger RNA COVID-19 Vaccine vs Other Approved Vaccines in Children Younger Than 5 Years.
    Toepfner N; von Meißner WCG; Strumann C; Drinka D; Stuppe D; Jorczyk M; Moor J; Püschel J; Liss M; von Poblotzki E; Berner R; Moor MB; Chao CM
    JAMA Netw Open; 2022 Oct; 5(10):e2237140. PubMed ID: 36255723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.